Denette Murphy
About Denette Murphy
Denette Murphy is a Principal Scientist in Materials Science and Engineering at Bristol-Myers Squibb, specializing in drug product science and technology.
Current Role at Bristol-Myers Squibb
Denette Murphy currently holds the position of Principal Scientist in Materials Science and Engineering within the Drug Product Science and Technology department at Bristol-Myers Squibb. In this role, she focuses on solid-state characterization, development, and analysis of various drug formulations, including oral solid dosage forms, semi-solid formulations, and spray-dried dispersions (SDDs).
Previous Positions at Bristol-Myers Squibb
Before her current role, Denette Murphy served as a Senior Research Investigator in Analytical R&D at Bristol-Myers Squibb from 2003 to 2012. Prior to that, she was a Senior Research Investigator in Discovery Pharmaceutics at the same company from 2001 to 2003. Her tenure at Bristol-Myers Squibb has been marked by extensive work in biopharmaceuticals and solid-state characterization.
Experience at DuPont Pharmaceuticals
Denette Murphy also has a distinguished history with DuPont Pharmaceuticals, where she worked as a Senior Research Scientist in Biopharmaceutics R&D from 1997 to 2001. Based in Wilmington, Delaware, her contributions at DuPont included research and development in the field of biopharmaceutics.
Educational Background
Denette Murphy achieved her Doctor of Philosophy (Ph.D.) in Pharmaceutics from the University of Michigan. Prior to that, she earned a Bachelor’s Degree in Pharmacy from Rutgers University-New Brunswick. Her academic background laid a strong foundation for her career in pharmaceutical sciences and drug development.
Specializations and Expertise
Denette Murphy has specialized expertise in the solid-state characterization of various crystalline forms, including cocrystals, salts, hydrates/solvates, and more. She is proficient in the development and analysis of oral solid dosage forms, semi-solid formulations, and spray-dried dispersions (SDDs). In addition, she works on lyophiles and freeze-thaw systems for both small molecules and biological formulations and has expertise in lipid nanoparticles for drug delivery systems.